Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Most recent policy updates reviewed: December 2025 Government Programs: What's Changing Medicare Coverage Expanding Medicare coverage for Wegovy is expanding for eligible beneficiaries: January 2027: Under the CMS BALANCE Model, Medicare Part D will cover obesity medications including Wegovy CMS program: Eligible Medicare beneficiaries will pay $50/month for GLP-1 medications under the BALANCE demonstration Current: Wegovy can be covered for CV risk reduction indication (not weight loss) Medicaid Coverage: State-by-State About a dozen state Medicaid programs currently cover GLP-1s for obesity, with policies evolving
Novo Nordisk, the maker of Ozempic, told Global News in an email Monday that its drugs are prescription-only medicines used with the Health Canada-approved product monograph
Apart from its primary use, semaglutide could also have some beneficial effects
NCT05934110
org/10.1016/bs.vh.2022.09.002 Giustarini, D., Milzani, A., Dalle-Donne, I
US$ 22.47
US$ 23.05
US$ 20.68
US$ 27.84
